Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Nov. 06, 2025 (GLOBE NEWSWIRE) -- First healthy volunteer dosed with BV100 in China in mandatory Phase 1 trialInclusion of Chinese ...

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / November 6, 2025 / Omnix Medical Ltd., P.C. ("Omnix Medical") and Prevail ...

The latest edition of La Marató de 3Cat raised 10 million euros, which will fund 36 research projects on respiratory diseases ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined net revenues of $8.3 million ...

Enters agreements for a $12 million promissory note and a $20 million equity line of credit with Streeterville CapitalProforma cash, cash ...

The addition of steroids to standard care significantly reduces the risk for death in adults with community-acquired ...

Illness severity, advanced age, and chronic liver disease were strong predictors of 30-day mortality among hospitalized patients with CAP.

Patients with dementia had a higher 30-day CAP mortality rate and were more likely to require hospitalization and ICU admission.

Streptococcus pyogenes or invasive Group A Streptococcus (iGAS) is a major clinical concern around the world, since iGAS ...

Mycoplasma pneumoniae infections have risen significantly post-COVID-19, presenting with both respiratory and increasing ...

Innoviva, Inc. ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty ...

Most children SMA type 1 can survive an episode of pARDS, a life-threatening respiratory failure, under standard protocols, ...